<SEC-DOCUMENT>0001571049-14-005521.txt : 20141029
<SEC-HEADER>0001571049-14-005521.hdr.sgml : 20141029
<ACCEPTANCE-DATETIME>20141029082536
ACCESSION NUMBER:		0001571049-14-005521
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		5
CONFORMED PERIOD OF REPORT:	20141024
ITEM INFORMATION:		Material Modifications to Rights of Security Holders
ITEM INFORMATION:		Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20141029
DATE AS OF CHANGE:		20141029

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			APPLIED DNA SCIENCES INC
		CENTRAL INDEX KEY:			0000744452
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MISCELLANEOUS BUSINESS SERVICES [7380]
		IRS NUMBER:				592262718
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0930

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	002-90539
		FILM NUMBER:		141178624

	BUSINESS ADDRESS:	
		STREET 1:		50 HEALTH SCIENCES DRIVE
		CITY:			STONY BROOK
		STATE:			NY
		ZIP:			11790
		BUSINESS PHONE:		631-240-8800

	MAIL ADDRESS:	
		STREET 1:		50 HEALTH SCIENCES DRIVE
		CITY:			STONY BROOK
		STATE:			NY
		ZIP:			11790

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PROHEALTH MEDICAL TECHNOLOGIES INC
		DATE OF NAME CHANGE:	20010504

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	DCC ACQUISITION CORP
		DATE OF NAME CHANGE:	19990211

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	DATALINK CAPITAL CORP/TX/
		DATE OF NAME CHANGE:	19980306
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>t1402045_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 16pt"><B>UNITED
STATES</B></FONT><BR>
<FONT STYLE="font-size: 16pt"><B>SECURITIES AND EXCHANGE COMMISSION</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 12pt"><B>WASHINGTON,
D.C. 20549</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 16pt"><B>FORM
8-K</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 14pt"><B>CURRENT
REPORT</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 14pt"><B>PURSUANT
TO SECTION 13 OR 15(d) OF THE</B></FONT><BR>
<FONT STYLE="font-size: 14pt"><B>SECURITIES EXCHANGE ACT OF 1934</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt; font-weight: normal">Date
of Report (Date of earliest event reported): October 24, 2014</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 16pt"><B>Applied
DNA Sciences, Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt; font-weight: normal">(Exact
name of registrant as specified in its charter)</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 34%; text-align: center; font-weight: bold"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Delaware</B></FONT></TD>
    <TD STYLE="width: 33%; text-align: center; font-weight: bold"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>002-90539</B></FONT></TD>
    <TD STYLE="width: 33%; text-align: center; font-weight: bold"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>59-2262718</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; font-weight: bold"><FONT STYLE="font: normal 10pt Times New Roman, Times, Serif">(State or
    other jurisdiction</FONT></TD>
    <TD STYLE="text-align: center; font-weight: bold"><FONT STYLE="font: normal 10pt Times New Roman, Times, Serif">(Commission
    File Number)</FONT></TD>
    <TD STYLE="text-align: center; font-weight: bold"><FONT STYLE="font: normal 10pt Times New Roman, Times, Serif">(IRS Employer</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; font-weight: bold"><FONT STYLE="font: normal 10pt Times New Roman, Times, Serif">of incorporation)</FONT></TD>
    <TD STYLE="text-align: center; font-weight: bold"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-weight: bold"><FONT STYLE="font: normal 10pt Times New Roman, Times, Serif">Identification
    No.)</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>50
Health Sciences Drive</B></FONT><BR>
<FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Stony Brook, New York 11790</B></FONT><BR>
<FONT STYLE="font-size: 10pt; font-weight: normal">(Address of principal executive offices; zip code)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: normal 10pt Times New Roman, Times, Serif">Registrant&rsquo;s
telephone number, including area code:</FONT><BR>
<FONT STYLE="font-size: 10pt">631-240-8800</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>N/A</B></FONT><BR>
<FONT STYLE="font-size: 10pt; font-weight: normal">(Former name or former address, if changed since last report)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-weight: normal">Check the appropriate box
below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following
provisions:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font: normal 10pt Wingdings">&uml;</FONT></TD><TD><FONT STYLE="font-weight: normal">Written
                                         communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font: normal 10pt Wingdings">&uml;</FONT></TD><TD><FONT STYLE="font-weight: normal">Soliciting
                                         material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font: normal 10pt Wingdings">&uml;</FONT></TD><TD><FONT STYLE="font-weight: normal">Pre-commencement
                                         communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d 2(b))</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font: normal 10pt Wingdings">&uml;</FONT></TD><TD><FONT STYLE="font-weight: normal">Pre-commencement
                                         communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Item 3.03. Material Modification to
Rights of Security Holders.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Item 5.03. Amendments to Articles of
Incorporation or Bylaws; Change in Fiscal Year.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As previously announced, the stockholders
of Applied DNA Sciences, Inc. (the &ldquo;<U>Company</U>&rdquo;) had authorized the Board of Directors of the Company (the &ldquo;<U>Board</U>&rdquo;),
in its discretion, to amend the Company&rsquo;s Certificate of Incorporation, as amended (the &ldquo;<U>Certificate of Incorporation</U>&rdquo;),
to effect a reverse split of the Company&rsquo;s common stock, par value $0.001 (the &ldquo;<U>Common Stock</U>&rdquo;), at a
ratio of between one-for-forty (1:40) and one-for-sixty (1:60), with such ratio to be determined by the Board. The Board determined
to set the reverse stock split ratio at one-for-60 (1:60) (the &ldquo;<U>Reverse Stock Split</U>&rdquo;) and approved the final
form of Third Certificate of Amendment to the Certificate of Incorporation to effectuate the Reverse Stock Split (the &ldquo;<U>Certificate
of Amendment</U>&rdquo;). The Certificate of Amendment was filed with the Secretary of State of the State of Delaware on October
24, 2014, and the Reverse Stock Split became effective in accordance with the terms of the Certificate of Amendment at 12:01 a.m.
Eastern Standard Time on October&nbsp;29, 2014 (the &ldquo;<U>Effective Time</U>&rdquo;). In addition, at the Effective Time,
the Certificate of Amendment reduced the authorized number of shares of Common Stock from 1,350,000,000 to 500,000,000 shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">At the Effective Time, every 60 shares
of Common Stock issued and outstanding were automatically combined into one share of issued and outstanding Common Stock, without
any change in the par value per share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">No fractional shares will be issued as
a result of the Reverse Stock Split. Stockholders who otherwise would be entitled to receive a fractional share in connection
with the Reverse Stock Split will have such fractional share rounded up to the nearest whole share. Stockholders who hold, of
record, fewer than 60 shares will receive a cash payment in lieu of the fractional share based on the average of the closing price
of the Common Stock as quoted on the OTCQB for the 10 consecutive trading days prior to the effectiveness of the Reverse Stock
Split.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">American Stock Transfer and Trust Company,
LLC is acting as exchange agent for the Reverse Stock Split and will send instructions to stockholders of record who hold stock
certificates regarding the exchange of certificates for Common Stock. Stockholders who hold their shares in brokerage accounts
or &ldquo;street name&rdquo; are not required to take any action to effect the exchange of their shares following the Reverse
Stock Split.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Common Stock is expected to commence
quoting on the OTCQB on a Reverse Stock Split-adjusted basis on October 29, 2014. The Common Stock will be reported for 20 business
days under the temporary ticker symbol &ldquo;APDND,&rdquo; with the &ldquo;D&rdquo; added to signify that the reverse stock split
has occurred. After 20 business days, the symbol will revert to the original symbol of &ldquo;APDN.&rdquo; In connection with
the Reverse Stock Split, the CUSIP number for the Common Stock has been changed to 03815U 201.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Reverse Stock Split resulted in a
proportionate adjustment to the per share exercise price and the number of shares of Common Stock issuable upon the exercise of
outstanding stock options and warrants, as well as the number of shares of Common Stock eligible for issuance under the Company&rsquo;s
2005 Stock Incentive Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The information set forth herein does
not purport to be complete and is qualified in its entirety by reference to the full text of the Certificate of Amendment that
effectuated the Reverse Stock Split, which is filed as Exhibit 3.1 hereto and incorporated herein by reference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Item 8.01. Other Events.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On October 28, 2014, the Company issued
a press release announcing the Reverse Stock Split. A copy of the press release is attached as Exhibit 99.1 hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Item 9.01. Financial Statements and
Exhibits.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0">&nbsp;&nbsp;&nbsp;<I>(d) Exhibits </I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">3.1</TD><TD>Third Certificate of Amendment of Certificate of Incorporation</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">99.1</TD><TD>Press release dated October 28, 2014</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SIGNATURE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the requirements
of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Date:&nbsp;&nbsp;October 29, 2014</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">APPLIED DNA SCIENCES, INC.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 4%">&nbsp;</TD>
    <TD STYLE="width: 46%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;&nbsp;&nbsp;<FONT STYLE="font: 10pt Times New Roman, Times, Serif">/s/ James
    A. Hayward</FONT></TD></TR>
</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 8%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Name:</FONT></TD>
    <TD STYLE="width: 42%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">James A. Hayward</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Title:</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Chief Executive Officer</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.25in">&nbsp;</P>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXHIBIT INDEX</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 9%; border-bottom: Black 1pt solid"><FONT STYLE="font: 8pt Times New Roman, Times, Serif"><B>Exhibit No.</B></FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 90%; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font: 8pt Times New Roman, Times, Serif"><B>Description</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">3.1</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Third Certificate of Amendment of Certificate of Incorporation</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">99.1</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Press release dated October 28, 2014</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.25in">&nbsp;</P>


<!-- Field: Page; Sequence: 5; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.1
<SEQUENCE>2
<FILENAME>t1402045_ex3-1.htm
<DESCRIPTION>EXHIBIT 3.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 3.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>THIRD CERTIFICATE OF AMENDMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>OF</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CERTIFICATE OF INCORPORATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>OF</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>APPLIED DNA SCIENCES, INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>* * * * *</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Applied DNA Sciences, Inc. (the &ldquo;<B>Corporation</B>&rdquo;),
a corporation organized and existing under the General Corporation Law of the State of Delaware (the &ldquo;<B>General Corporation
Law</B>&rdquo;), DOES HEREBY CERTIFY THAT:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>FIRST</B></FONT>:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
first paragraph of Article IV of the Certificate of Incorporation, as amended (the &ldquo;<B>Certificate of Incorporation</B>&rdquo;),
of the Corporation is hereby amended and replaced in its entirety to read as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&ldquo;This Corporation is authorized
to issue two classes of stock to be designated, respectively, &ldquo;Common Stock&rdquo; and &ldquo;Preferred Stock.&rdquo; The
total number of shares of stock which the Corporation shall have the authority to issue is 510,000,000. The total number of shares
of Common Stock that the Corporation is authorized to issue is 500,000,000, with a par value of $0.001 per share. Each share of
Common Stock shall entitle the holder thereof to one (1) vote on each matter submitted to a vote at any meeting of stockholders.
The total number of shares of Preferred Stock that the Corporation is authorized to issue is 10,000,000, with a par value of $0.001
per share.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>SECOND</B></FONT>:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Article
IV of the Certificate of Incorporation is hereby further amended by adding the following paragraph at the end thereof:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&ldquo;Upon the filing and effectiveness
(the &ldquo;Effective Time&rdquo;) pursuant to the General Corporation Law of the State of Delaware (the &ldquo;DGCL&rdquo;) of
this Certificate of Amendment to the Certificate of Incorporation of the Corporation, each sixty (60) shares of the Corporation&rsquo;s
Common Stock, par value $0.001 per share, issued and outstanding immediately prior to the Effective Time, shall automatically be
reclassified, combined, and converted into one (1) validly issued, fully paid, and non-assessable share of Common Stock, par value
$0.001 per share, of the Corporation, without any action by any holder thereof; provided that no fractional share interests shall
be issued as a result of the foregoing reclassification, combination, and conversion:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD STYLE="text-align: justify">to any stockholder that holds, of record, fewer than sixty (60) shares of Common Stock immediately
prior to the Effective Time, and, in lieu of such fractional share interests, any such stockholder shall be entitled, upon the
Effective Time, to receive a cash payment equal to the Share Value (as defined below) of each share of Common Stock held by such
stockholder immediately prior to the Effective Time; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(ii)</TD><TD STYLE="text-align: justify">any stockholder that holds, of record, more than sixty (60) shares of Common Stock immediately
prior to the Effective Time and would otherwise be entitled to fractional share interests pursuant to the provisions of this Article,
and, in lieu of such fractional share interests, any such</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">stockholder shall be entitled,
upon the Effective Time, to receive one whole share of Common Stock in lieu of such fractional share interests.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">As used herein, &ldquo;Share
Value&rdquo; shall mean the average closing price of the Common Stock on the OTC Market&rsquo;s electronic interdealer quotation
QB system (&ldquo;OTCQB&rdquo;) for the ten (10) consecutive trading days ending on the last trading day prior to the date of the
Effective Time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">From and after the Effective
Time, (i) certificates that, immediately prior to the Effective Time, represent shares of Common Stock that are held by any stockholder
that holds more than sixty (60) shares of Common Stock immediately prior to the Effective Time shall thereafter represent the number
of shares of Common Stock into which such shares shall have been reclassified, combined, and converted at the Effective Time pursuant
to this Certificate of Amendment, and (ii) certificates that, immediately prior to the Effective Time, represent shares of Common
Stock that are held by any stockholder that holds fewer than sixty (60) shares of Common Stock immediately prior to the Effective
Time shall thereafter represent only the right to receive a payment in cash equal to the Share Value for each share of Common Stock
previously represented by such certificate.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>THIRD</B></FONT>:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This
Certificate of Amendment shall become effective on October 29, 2014, at 12:01 a.m.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>FOURTH</B></FONT>:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;That
pursuant to resolution of the Board of Directors, the proposed amendment was submitted to the stockholders of the Corporation for
consideration at the annual meeting of stockholders held on August 28, 2014 and was duly adopted by the stockholders of the Corporation
in accordance with the applicable provisions of Section 242 of the General Corporation Law of Delaware.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">IN WITNESS WHEREOF, the Corporation has caused this Third Certificate
of Amendment of Certificate of Incorporation to be signed by its Chief Executive Officer, on October 24, 2014.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">APPLIED DNA SCIENCES, INC.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 47%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;/s/ <FONT STYLE="font-variant: small-caps">James A. Hayward</FONT></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Name:&nbsp;&nbsp;James A. Hayward</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Title: Chief Executive Officer</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>





</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>3
<FILENAME>t1402045_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 99.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><IMG SRC="ex99-1logo.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Applied DNA Sciences Announces Reverse Stock
Split</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>Stony Brook, NY. October 28, 2014. </B>Applied
DNA Sciences, Inc. (OTCQB: APDN), (Twitter: @APDN), a provider of DNA-based anti-counterfeiting technology and product authentication
solutions, announced today a 1-for-60 reverse split of its common stock that will be effective at 12:01AM on Wednesday, October
29, 2014 and in effect at the opening of trading on Wednesday, October 29, 2014. The reverse stock split was approved by the company&rsquo;s
shareholders at the 2014 Annual Shareholders Meeting, held August 28, 2014, at the specific ratio determined by the Board of Directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">The reverse stock split was enacted to help
the company become eligible for listing on either the NASDAQ or NYSE MKT. The company has applied for listing on these national
securities exchanges because it expects that the listing will broaden the company&rsquo;s shareholder base to include more institutional
investors and larger retail investors and also improve liquidity in the company&rsquo;s common stock. However, the company can
provide no assurance that the uplisting will be approved and, even if approved, that the expected benefits of uplisting would be
obtained.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">At the effective time of the reverse stock
split, every 60 shares of APDN common stock will be converted into one newly issued share of common stock, without any change in
the par value per share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">The reverse stock split will reduce the number
of shares of APDNs outstanding common stock from 836,157,272 to approximately 13,935,954. Proportional adjustments will be made
to APDNs outstanding stock options, and outstanding warrants. The number of authorized shares of the company&rsquo;s common stock
will be reduced to 500,000,000 shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">As permitted by Delaware law, each holder
of fewer than 60 shares of common stock prior to the reverse split will not receive fractional shares in the reverse split, but
shall be entitled to receive a cash payment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Noted Karol Gray, CFO of Applied DNA Sciences:
&ldquo;The reverse split has had very solid support from shareholders, and from the Board. We believe the changes in capital structure
can strongly benefit our shareholders.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Holders of shares of common stock held in
book-entry form or through a bank, broker or other nominee do not need to take any action in connection with the reverse split,
and will see the impact of the reverse split automatically reflected in their accounts. Beneficial holders may contact their bank,
broker or nominee for more information.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Additional information about the reverse stock
split can be found in the Company&rsquo;s definitive proxy statement furnished to the Securities and Exchange Commission on Form
8-K filed on July 21, 2014, a copy of which is available at <U>www.sec.gov</U> or at the company&rsquo;s website on the <U>Investors
page</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>About Applied DNA Sciences</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">APDN is a provider of botanical-DNA based
security and authentication solutions and services that can help protect products, brands, entire supply chains, and intellectual
property of companies, governments and consumers from theft, counterfeiting, fraud and diversion. SigNature&reg; DNA describes
the uncopyable marker that is at the heart of all of our security and authentication solutions. SigNature DNA is at the core of
a family of products such as DNAnet&reg;, our anti-theft product, SigNature&reg; T, targeted toward textiles, and digitalDNA&reg;,
providing powerful track and trace. All provide a forensic chain of evidence and can be used to prosecute perpetrators.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">The statements made by APDN may be forward-looking
in nature. Forward-looking statements describe APDN&rsquo;s future plans, projections, strategies and expectations, and are based on
assumptions and involve a number of risks and uncertainties, many of which are beyond the control of APDN. Actual results could
differ materially from those projected due to our short operating history, limited financial resources, limited market acceptance,
market competition and various other factors detailed from time to time in APDN&rsquo;s SEC reports and filings, including our Annual
Report on Form 10-K filed on December 20, 2013 (amended on May 1, 2014) and our subsequent quarterly reports on Form 10-Q/A (for
the quarterly period ended December 31, 2013) and Form 10-Q for the quarterly periods ended March 31, 2014 and June 30, 2014. APDN
undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances
after the date hereof to reflect the occurrence of unanticipated events.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><IMG SRC="ex99-1logo1.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>media contact</B> Mitchell Miller, 631-240-8818</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>investor contact</B> Debbie Bailey, 631-240-8817</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>web</B> www.adnas.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>twitter </B>@APDN, @APDNInvestor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>



<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>ex99-1logo.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex99-1logo.jpg
M_]C_X``02D9)1@`!`@``9`!D``#_[``11'5C:WD``0`$````9```_^X`)D%D
M;V)E`&3``````0,`%00#!@H-```)/P``'&0``"6E```Q9/_;`(0``0$!`0$!
M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0("`@("`@("
M`@("`P,#`P,#`P,#`P$!`0$!`0$"`0$"`@(!`@(#`P,#`P,#`P,#`P,#`P,#
M`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#_\(`$0@`/P%J`P$1
M``(1`0,1`?_$`1<``0`!!`,!```````````````(`08'"0(#!00!`0`"`P$!
M```````````````!!@($!0<#$``!`P0!`0<#`@<````````%`P0&``$"!Q$5
M$#!`(1(3"%`4%R`B8#%")346&!$``@(!`@,%`P8'"0L-`````@,!!`41!@`2
M$R$Q(A0'03(546%Q8B,S0E)RDB06-Q`P0(&"TU34E2!0D=%3DS24-44VH>&B
MLD-C<X.C576U"!(```4!`P<'"@<!``````````$1`@,$(3$20$%A,A,4-#!0
M47&!D:$08/#!X?$B8J(S<B-C)`45-243`0`"`@$#`@8#`0$!``````$`$2$Q
M05%A<?"!,$"1H;'1$%#!X2#Q_]H`#`,!``(1`Q$```'?X``````"@15(````
M````H<2+)K?-CY*H``````%I%V@`\`]$[&'BY_&Y,-D```````"A$(TBGA&[
M,E*7Z```4+/+M/`/1!YQK#)&$O3XSUC7B2JQC[>MQX\V_@R]H-KN?7V[6V]2
MYM?;LI-\%M$4R5A[IY!ZY\9W%OEUEG$:8G1C8N/L3[]:A[CE:U0MN>^=O27N
MM,S/MZU)B4]1LV4N;T^R<Q%D@490(^%VG<669A/K(JF-B9YAHD#Z3Y_<73Y?
MG;/QL3H:>8J[V?#VOA='&Z&M+SOT38"93(U$(B6)\!EHPT7\0J)9%]$KDZ+^
M_P`/8]=J;=NWIIG$NOL1.H%V^[JZ$_;E4N&.$]O-K]F'D=GLB<+93K:.9&\F
M01<,QF93N,:E2^S#9,&[TW"%GJ^5N%W<G\3J8,M=>LS<T_MU-N-_EOI<FBZR
MPB/1,DM<[3"!E@C^3H(5&ZLBQ$Z7MK7PS:*U*[N<6_K75^W&-=WD'L4]O7/*
M?=^VL^*4U1M&<Z]W)15NT"VR`YL;-8YLY*``%3K8T^9D8SR.$*Y1V9Y4*@H5
M*%0``5*G$PT:[S5GGEE7YMILMCF/RY)H4RBD.Z<P````````$$@``````*&J
M,@`3F-GY>X``02$*8*_0```.,3TYQ\TQR.>+FGF<X<BH``````!8Q>IV````
M_]H`"`$!``$%`OH?-JEFY]>P^\E^51IQ6FY7(IE">^>'0S!]^@D4&AVK9R@\
M;K*IH)#R@XLW\%L;<T6UYC-MT3J;YZ[B\$D#P9K*"1D)'%2"PSN'4A`,75LK
M7L0+BA*;5XT?(NGC1BB/+BBR>W./SJ6#RU7;KIZS'H,"XHJFLX0;I?(,P(,:
MGUQZ<=?GC09V$^/G%H!F;#)NN:<'0K5Q:_DZE,99/+9XWM@9$.'&JP\M&$B!
MT*)I%P@Y3(&!(G%!PW=).R#`?@V>-'B#>1Q]V[4531P'R>.%E]X;!<Z_B,5A
M4GF+A<4LY%&-/2ARNTB6YH/4?^3TU%8@_D6:DCC\D[0K\D;0J(ES)L1V[EE[
MJ$Z_B/QK&26+:'/F`Z\%@"F^B,=&DM(;@D@DANW<,Y@:F@B6T'&#S=,HM;_J
M+:$J$3+:*1R(027;(P*[7V[N#18V`1B3FBEX(=T"-%1Z$F70#1+'4#-_KEGL
M(JRT='M##S4?U86DC<?"6&IB3?>1TJ@/U[\?P,"-Z0*)@,P[V`2U[\?Y&F+V
M''(9AO;8&D5GL)G41A#[Y"&-SK_B^#DQVEVH27R:73#X]:@&:1>2+>6OW<^B
M$<G$PA-PRDP/,ND;!KI.PJ.ZL?2;.5ZB+Q5M%=I3EZ_Z1L&NC[`H-(@[,5@I
MBICS6Q(:A/8B$E6^X.,T_%YN&/Z=DNSHF$A,-GTYV$B^G@G=+T/M7>1C9,8-
MN]O2*.'W'R)V#KR61:>Q=AM"92G:$$F@B;F\=Q[MK8VM7)0(_D^YY*..05X!
MTT%&D$M10_7[XSJ`7(]RQ8?JH'-09B9DY]L<=.=.'2,&U[.MO$I!IB&ET'+.
M-[!U&ZT^!V#B1T''#X(Q#HT:0WLWCFV=*'9Q"I7MN"9/=M&6YQU/X%!(]'Y'
M/=HUL#4,2V%A,="SZ'*1Z5C!*K:::'6LB^T\Y3R=ZB3QF;N/%Y$+SUB@,^XU
M)7W&I*9;N"CF?Y,:=IC#+,1\9Q!8-"JUD&+L]V=G%<?HX[.*X[>.SCLXKBN*
MX[.*XKBN/TR77D+E^,N^+T?Q1ZA(H`8<S+;.VLM1:&8PI7BU<6KBU<6KCZ+N
M_=<H@Y]*-;IVRM$/BP/;W!1P'&67@\L_37NYU[N=>[7N5ZJY\"2_UO[RWI[G
M_]H`"`$"``$%`OKG%\J4242O],;I+XJRK_)>PO=+RJS=?.WESWO]3!H@YKI(
M^LA0_P!M1'V[VO\`N0&CW&/2A]=''7N[12;K>=_`1]JAE3>39+.BB":\E6.W
MP+*"T%)"[DMVKF0MT._8.6C?+%Z&SO94;5U1W*F0]3!5FO>X]RS0KWAE>Z-X
M4;.<U//GO@A+!GFFQ!-5DB5G)]PNE<T0*)(G'+,&^4D#QFX;=_@LLEGU\K3<
MJ07JW6;6OUBG=\U72?6,4_4:KTEZ4`*Y7Z=GW_[:OV\6JU[>#OGE5LKVKGBN
M;US7->=<?4O/N^*X\?\`_]H`"`$#``$%`OKE[VM9-3!:WTORIPNCDE'[7^QN
MNC;/SJZZ-K_S[]^Z60MU(C6!1]CG@MDK:^.7H5>$D<NHOZN2)\-%5ET?+'P!
MM=:EH_9)LP5S:@DPV&8^Q!9,&U!>^U!KJ\]\];.5[9LR^%KID*M@_P"$[/<,
MTGJ=J?-72M[I/^?;><X.D$\.;98\X]\88JNDU'9ARFL/R2#I(JV$L6"BH9-R
M7:8!6SE!QW^22:N%PHZEQK)&LLA5KVN*O36V*;93(;?.]Q=?VNDC2>-NHH^`
M\^WS\'S7IPKTXU?+U5QC7%JXM7IM7/\`#O\`_]H`"`$"`@8_`N?$*UPPSM1_
M-B".1S#*/&5H7],AM28XV]/DVC&.<TLXT\N[>)VQLS+TCC8O3M"QUC#>$QL=
MI'Q&2:!B.K:T])>T<;'W>T<;$OII!PPR%(TLY9#+75)*R%JAD4\<6[/<EA=V
M<,@DU$+N']>QC"I<>&X;JWA]8.BIHX]UC-+2O$/\C2MPE,5O+I50ME8?>$;0
M&8_S9/$?YLGB,']?*WJ]P2&&79Z?<#BJZ8GF76HL_C7^(/\`YTB@SAA>UG48
M0[RY>2GJ"_:3-1P*KWC%$VXLX*OJ/AA]2`YV&6RVB@J^G1T>%J^L'6MGPL=:
M;=(@BHW$91ED&.)R#73L'$DU_1A(8M[BM_"%WN+Z1K8IUUK@1-JXR)/E'&1?
M2.+B^D',^HB4])#[D>LEY9#8+0B6##T9%I%IF+%"%YQ?_]H`"`$#`@8_`N?%
M=80Q1.4N;%#XR<6+"83YA@-[5\B.>1.Z!\O+EN\1R.4<(X87TKB:%-KFZ!\"
MFX8=W4APQJ%W5PVDT>!^0QT<!HZ0[PZ1DDFV(EM,.F;K*-\>YYS85O!3G]\[
M`4U0]^\/);#L$E#.>)\9\NM-(<<@5U61#CV"VO8O8,1UD;A^9*S%H!24LYL(
M6US07[UB*"*65ANZQB9:7+ME@^_&:D-UV22'>8W.,E>8*!Q'M=F@=2S$DV(T
M4-I#C4RSB62I:9')D&"4AJ>(X<W-ZQAW61>T<-+XBY(4NS@\5/(9KI'"R>(X
M:7Q!1L@DL].@?;DU5NR&T6!0N1:!<0N(*+B&89A<0S>;O__:``@!`0$&/P+^
M\AIOYQ5V^'^[,/'Q&Y!?BLZ,]"OV_P"4,>#5M7`5,4J>P+N89-ZW,>P@JJZ-
M1<S\Y,XJYK<]4:^1.W;0+0K%3"_520]&\%8ONX9S2/9X9D=8_?ZF,NY7'U,C
MD-/(4;-M*;5S4I"/+(,Q8_QQIX8G^Y*]E;]3&TP(`*U>>NM7$V3R@)-:0A$G
M/=PFU5<JQ6L+%R'I,6)<ID<P,4P9D3`AGLF._@W-,5J4),8PY@06`1)&9E/9
M`B,=O'FL7=JWZW.2^O3<%A74'3F#G7)#S#K_``,JCSG+;@D.96#HF/67S>XR
M^^=5T53\_CGV#PY%G*3B,2>L1AL,9U4]/7L&U8B?-6^SOYI@?J\=/>&]HVS'
M5T74\DR"N#,Q_OAT30JR4S[8DN"R.R<'C,O?B%RC,697N"R<3(P;TL9YA,'$
M=OV8]D=ND]W"BR0<CXF0C[+H3*QT[93RAR1!ZP/8/,,1.D:_O(TKN;Q-2X?N
M5;.1J(L%KW:)8T6=OT<1,3K$]L3';$Q/MB?;&G`MRF2H8U93H!WK:*@G/R#+
MV!!<#9I6:]RN?N/JN6])_DL41`7!6;ME%2N'OOM.772'Y36D(1P3<7DJ&26$
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M:"B?#(]_-$]VFG'D:^6QKKWBTJ*NUFVO`,D7Z,#9;/)';/9QO`]R;ZH[N1:R
M0E1JU+\WBQNC7R1N`O\`9LM7,+\O'ACI\!\5RV-QLL^[B_=K5)9^1#V!)Q]'
M`.KN582R.9;DF+5,'\8&!)`<?1P!Y7)X_&@R=%E?N5ZD'/R!+V!S3P#ZSU6$
M-CF6Y#`:I@_C`Q<D!1]'$-OW:E%4]S+EA-8/SG&$<#:J6:]JL?-(6*[EN04#
M,P4BU9$N>68[>WB:%7.8BS>&=)IHR-1MG7Y.B#I9K'T<$UI@I:QDF,84``"/
M:1&9:"(Q'MG@JV+SV'R-D->:O2R52RZ.7WOLDM,^SZ./,8S2,UFK'PO&-+MB
MI,I-MF_R_A%63'@C\<HX9GO@6;W)C_/%\2?6,NM?M>%KTG>(6FLYYXYBTF8B
M>SA&&;_^=T^2JA(H(#LJNKYO>9\16@;I-GOF2.=9X)N%V1N3%*+6?)VBG)`,
M^R%V)57=`1];FGY^"R&+Q&\,."O$QV+&S*=/^_J(E@L#\I<\35W!C,=N"5^#
MJL@\1D@(>S1\)62#G_RPGB*6&V96N7N7FBD&5.+)1[>DLZX]?^3K/'[)KW^L
MO_J_'[);W^LO_J_`WL]@6[<OR]JYQS7=8ND$QR/UT&8ANO=,>S^XS.8Q\\N2
M9T<;CW?T:U?/I1:^FNOF(?K1'%7/[GS^8G<.?IKR@M0Q+55?.!UT>9\PMK;[
MN4XEGC#M[(XWWZ?;AM'?_45S75+,L8WEI+-JGUEDV9*$:J%BQ_`YYCC<6^MY
MY?(KQWQ5]'&8^DX.=(@(M%*RL`]=6I50P!Y1'5AZS/&$VE5R=C);3WLL`37L
M%`DDW,8A+F*">C%NK:7`R8C'46?=QG=I7,I9QVU-DJ@'5JQ:RUH$M36*4>J/
M-VK+9'G(9Z:@[.-O[YV9EL@W&%DE4<ECKK0YVC($TJ[2K@A=JI:2LXT(>99Z
M3''HE;7KT[2Z%E>O?R/R)-'7^(N-F3RCK\#7XM(U_P!%S?M[^,GB=Z9[(X39
M6V7NQR$8ZNVXVQ:JZ`]@(@24NQ;<1?:F)<BQB(CMXV]F_2;<6<R2V7DULMA,
MG5:AMFL;%@2.J"DA=79$Y@0Y.=9Q$QQ6],$Y%^*V_@Z`7LITYF>LPJZ+EAY(
MYN1S@"RM*H+41F9+@]Q[9RN293!U:IEL?D&*.6@\^FBPHZRJ\%T[&FH$,]^L
M<>E&R,.XZEC=&$PP67@PU3Y?H5*RJ_.&DPIC7:L^41TXM9#$9C(SG,=2?:(V
MRH*MSHI)EA("H`;6ZH04#/.7S\;@RE(B7;&]D%5FQI!)9;93K0T?D)75UCY^
M#WFW*7YSS<;9SR]3`JW(F&.A+>89LFY@+UEG/KS3P&;ES&9B'-V_6O&7.[GZ
MQ*5<84SJ3DU?^E'",KG<SDISF7JKR$,226)05H>NKS'7`W73T..>9,?FXW[L
M9KRN9?:J;PX5Q,)DPWDM5D5Q)D\W2&VD2")]WFTXR.+]4;6X\1O*UD+(OR5B
M377KD<Q$2TI4\UV.K,RV7QR_).G&PO3;:M\@9NSRE4\DI_2\SCU>5HU`ZZ)[
M$7&.YV2/>(:1W\8_<H9C*9#-4J]A1\XUDX]AW:Y(L$*123](@YY=63/'KGG#
M5!CBK]K(2N(TZLU&9M\+^7QD.G&5W%ZM;KW`.7OVFS7HXNHQT)26A+*;;46%
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MLP?*>2ZM-B+4Q!*Z#B#GDOL&=T>[P*L3`GFL):^)X^N6@^=CI&JU1@I\(L>K
MM#7\,8CA^#K9C,8*J-TRO45ZI;4M3R+>PZIKD^KHN.8?PM.SA=_'>NN%)#/P
M+&1;3M*GVA8J6:RW)./;$QQ^W';_`/;4?S/'[<,!_;,?S/$.SOJ5LC(V!C0;
M3;RAM1'SN6A9L_E:\1E<;N7;FX55IZK/@F64&3I<FFC@KF8/;R_C)GFCY.*&
M%O\`J!DL4AY#53E;SR.M6+W$C<($FV%26@]2?=]O'[<<!_;4?S/'[<-O]_\`
M[S'9_P"CQCZN4W?@LCD454JN7AR-)<6K`C$,=R=;LYRX$UD)@<00&$\P$)=L
M$)1K$Q,<>SC*[:<V*S+:P92M2,F-:_6.&U7&,=I+Z@Z']29X5LHO3XLZ['AY
M#$9J%6+%8$#X*_-9K'Y6TE`^YSRHH&-"X]4,CO'$WZEG);?NRW(V%?HMZ^QS
M;#_*V!^Q='B_`[-/HXO9+:FURW;MJWD31;IKZC'4\HE"9EX#6F;*1:E@Q,\A
M`6GLGBIZE^H^/^!5L*N(P."+P.%H\_E_T>2-J:]<V$TB;]HQDQV1$<>I.8V'
MC(S5K'Y.\67Q,^+SN,=;4OE%,&MK#58B)B5^,?DGC#5=T[;G96S<3<BY;4Z&
MJ;9./"SIC9TM6;3%ZK'P`M<%,\>D^1Q6$OV<+A?*A=NU:Y,IXY2L@<C%AL=B
MH!,1_%QM3<",/D'8*KAP59RP(*:"&Q7RP\C7^Z):N'L^?BYZA[-V[0WACLSS
M'F=NW:2;YA9/D\P056QSRMYKA@L5]HLM8F-.,5D/U.P_IAMS&N6ZX:L!C%9"
MY`'SFNL=VF5Z7MB.2#$5@N.W77BIZK>G"1OY0:X5LUAM(,[2P5%:34F2#S2G
MUH@6`,PP2`2'BCMK);3G9&V5W$V,O:LA93UNC/O1YOD>^5=O(H`TY])(NSC;
MI;4**^8V:NNK$`1PN7U:P)Y$PV>P+"SK"83/9,ZQ/?PW:\;,/&VKBII7LQ*G
M5ERDQZ;RZCB\K7ZH]Y!)]GN\6]IXM#LMD^6NYP4U29V;C<@BQ:E"H[>FN(T'
MZH\+Q+:5E>3C:-RI-`UR-J+)5+`BCISV]0B*(TXL[4S-6QA\BS(WK=6+JI6=
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M>WY^/4;,7\+?3@LIBSKU,D^N0T+LE.(@EI?W'J*C_P`'&9#9&"C>&T,S:*VB
MK`$XZY3KTX:FNQ=JM90N>G)#!+:,1/?QMO<CL2K;V_<*ZW:7A+,$M3$^9T\D
M4VX+D87EEM#J>&9[)[)X7MVCZ-;?PF9DE)L;D9MNBE(<I1!V(*VDL<CGTUDA
MEL?BQQM\,5BE[]S-9X5]P5TTAKJ93:FP;YI5:*TPE%=O*`1"R\/?'&V=UJ].
M9].<7MZP-W*O*N5+XDY)RP1Z95Z?6L.^[\*_<F=9_<EV1K31S,!R(SN/@%71
MT]T;,:=.\F/Q61K'LF.&6Z57]9,:O4AR.$`BM+7']*QG;:7I'?R=4>)1N;:5
M?<"P/E;K>OX?*(T[)&964H(H^NJ.!AFR-R(9,1J)Y;4-?;$,B]$3_@CCK5O3
MO=ME/^5KW6O7^>JX8\&UGIQO!2UQS,:RV]8+&.\S85N!`8^77A[=FXJWCL4Y
M=95:D]LV[+K<!RN9V&Z9Z[)CE&)G7C'IR7IYO"SD%4JJ[UE;;(+?;!(#8:`>
M8'E$VQ/9IQ^S3>?^?M?UKC]F>\_\_:_K7%:C3V3NQ-2DA=>NJ*RYA:$C``.L
MLF9T&/;Q_P`.;F_X;_67_9L_<_T#W_\`3?\`D_=R@`)&9XZ\``,<Q$156P(B
M,=LD4]D<92ME\9D,58/<5ART9&HZFXU32I##!6X1*5R0S&O=^YZL9*YB\C5Q
MU_S'DK]BH]5.YKE$G^C/,!6[4(U[->S^'S^L&W<=>;,3$6^CT+PZ^T;M>568
MG^5PZ[MS<S<$*QDR3GR"UC0CV\UZ)KV:X1\I=3BQ6P.[`AU=GCN[8RS+.+L3
M$]WNBA\QIXH()XJ[9"S?S<#`0='%U5TJ[=.ZSF6UA2B0'Y7$(?-KPC<.Y#5E
M-SB//52OQ8W"$4:%-?FC]*O1$Z=:8B!_!CV_WJ7MC;E2E3D\:BZ>7OHFRQI6
M"8,!CD$8UYA/)H4E!^*=-.!=;5G\G59.L6LTT\9A4Q/M0IW0KS'_`(2BGA5K
M>N9/(G'*4XG#<]*EKI[CKQ_ICA^7DA7`X[`8JEB:8Z?8TTBOGF/PFG]X]GUC
MF9_@GNE/Y(S/'8DN/N2X^Z9^;KQ[K/S"X[B_-+_%Q_S3_B_@-'XQ\$^(>+X9
M\2\AYWZ_D?-?;?3R<1IIW=GT?-\W[S__V@`(`0$#`3\A^/9\FH;B65H!;XHV
MKH"7+G$)%FUM'#F;(<$`*TW!.T!2GH]V"*W7`_'IUX0L`\E.0/\`S>RB[)3R
MT+RPHJK@IRN*J&8PY;*4"+BN`AKFNVK%P%EXOY,J0ZG1W8+<=AF(FAIJL4OU
M,Z)0.AND1I0*,EY"]X,'ED-R*A4I<J2A`'9;<DI\!0W%&>"U:%Q3CE!B#,,2
MP%B9#R18YB]&E9/%P#IV8A^LC`,^-X6LU>[+8Y"VNE$IBZA5(7&IGR[E(PA@
MN<9FL&!J(6C_`!/+ZXN09%&Z<Q6F(J:*QL6_5$#6.[P5D%.B)!6@K2"VX%'M
M*ST8"`\')4J`!QA[&,04[`I>()X`QOO[_3K$9(/EUB7A!0)@$$&0HPJ]S*RA
M;D#"WI!@,I0B@I9L\AU464I4\H<*='`S!&H*9^',)5(Q$JH7*-#=QS8E]XZ^
M:7#>TDZC55'@I<U=3_4]GK6FDCD`1%)L%;GB##(&=,Q44P1Z1#@#/.'/5LR(
M-LFGRDAV4`C;9.8_E1:Y<"(+"B%^!LZ=%K@8[!*R5[$0A#!PH*I'9#`K[R0/
M29`?B4V.<Q0D6SGPQRN`/-2<'8/@1PZS=WF."5"6Y50\>-.[<8N^F<K_`-8Q
MGVGP[Y_*`D"??^7K58Y+IGIE)5H51H]Z%2"FBKCK-MB[Y]:<-$)A1'VT.C4=
MS]26XS&*AK-780@0VDWP9L2:**L3Y]_B=Z3:D=#K!AJ*>X.9J*=F)J*-+B0M
MNBXX@S$$J7GB0R->S+U$U<4+PJ@%_=?#4K>>Z!/$M>[A51]AK!>#.(AOK4:G
M,^,F.6!FKC,$X=4"]7MA"?5EH05MT0T41=[T@MW@.%V+,S^V(AV3,P4K5Q#'
M&BN-L5,'PAR_?7!QWA3HBZ)02T/@1WIB-UOO(*(P"8OI-VAU08`87WRV'2+8
M6S3JPU@00*)5;OEAKNR!,N2SE@XY%68H+JI+94)35*K960+F_2PE12ZE*3]K
MB5TJ"KFC>H(XKF,61')'L0\*@MBW9;M@MGHW('##0]!<:.UP,,*F$5*F&YI@
M/E.]"LTTY66/[=,9X06!PIF4P?J__P"8MFK?7EAUS1&CU&1CUFQS4C-ZA3"Q
M!)9RQMGA?L^U&XN=@V>=PQ!)6(KOIE<-KG$,*.7A',MUVZ/TW&,B6$,@-$9P
MLU,OA(IU`HHC!IN5%X;$JM*7,B*&H)3$?*<<P4ZBX2T(G$9;,!3,56Y62DJ%
M!AJL!2:!4&>_63<EJN1%#EHVH(9AUHOUH5`E[C`78(:W8WL-P\F`P,46(JAE
M"K&@NW.N)78@5-55RV7C6KE[J`$)">*8`8HCJ"$22)$$J;-R%A*Q%O;ZE^IE
M"YB;GTA]U*.IF2"^/AL5CRT(\,95UIONT4`2V^I0H:ERM2GF#[>4;\>)9&9!
M$0/1>P];(\T%I0E*%W=0QZ;;@)85[P_G]J@SCI%A46MW&RB/)1H+U%VCZ%"$
MS/=M.&M%.#+/WM$<U^LX<05E'IX9@LG!Q;99K(Z4ZH;D_IX2,B#,R"TM3-0]
M-.^L<6>=G--)1!'@LU+?$XZ2FR\0AO;3R`F<+MP46US.G;S'>%-8['Q1P\S@
M!(-<`D=.3H2]E:7_`+5YSB,QU[PO#T`1[7DRF"<Y)2^8`UZ6D0F`HH_B8J58
M=&I[/0P]Z5C9TF=E9ZP/1U_"JC1UC#BQ4@&UAOWP#!;F$LFXXUO!^XS,.=-1
M)!O"I6;^W'TE*J(>7V:E=W'?U<0?52CUZW*Z%]9WN47_`-XG+_LKQ**3Z\SM
MG7CTRG?\_D96*S*FO/EZO>5Z<RGU;GD_7Q^HAW*=]5N4>O7:4GN?.936?KZQ
M*%]VW\2O7KF!17\5S:>($IP1TYR<9D_Q'V:(8`YE6@!:X+>&"2Z9<`Z_:J`9
M:1JSDR@_#C49M$0L*`C7V/U/11^IV/L?J<%%]@E.KOK_`,_I'3">'@[T_P#I
M:FA4$I?,F"%-7)*5KEHM&.`//=PG%Z?%![J.4_7Y/,ZA]/NU5'_<C^C^%OR/
MA_82OJOQ,_\`28MU^C^1\B,YGZVLUN=??@IH4:.-*Z/;CX/_V@`(`0(#`3\A
M_O!@=C@[P.OIHGY_K%Z+F%U%#6R(JN?S,$.R)KZRUAQ.D60:[RW2_'XQD7DZ
M1M]M'^B/:O$E^G\/S$3'\$S]Y33ZRKN]H)Z:TQ5%,_<YJ3H9?%^6>#Y`K&>.
M^\]JE8<`)9;EMD\3>ZL.RW_)@JCJ4\[K[125#(>E6AY8`=L2QIY(VJM1Q=%U
M]?C&&S<9:A;H^1U[2[*[/\.:8B'H?P[_`'6(K`Z#>/80K!D&'Y3L/O"E!,PY
MCO8V&@Z:F"--DOXVWD+=&>(P0^\>>]&6-A18+W`BM"(>PC$<45'%5AY(4!UL
MSX#F5,B5K@_7Q\V,+M0W])9Q\!_L#"XY8/>$I(]&)<6DR?V,^DJMHPY'U_@"
MEW,[%F:W>+GK.[[^-CF5:S+$)260&K(2K,<2Z!"BODANP8>50BF0B%=EYE&%
M67[R_>"#*SS?[%OCX4[RI3K*=94KYW__V@`(`0,#`3\A^/LO^M;M3S*7A_K,
M&\8SUK.DR;A_Y*/'39<#+K!UR5D7%5C'5\;=%S1&2%X*W/2/ZG@BEO\`D-7/
MD:^T9AZ!Q*E?4%97^]^H)ZWG]0E<'5Q-GR%S:1V.,=X^-;44T9X,1#+LWWQ-
M8)^%GM$1,A36&IHGPA1XX?S$.=D^:^,--\RA^N7%)T^LHS.Y_P!AM?:_<W@]
M'6`CO12OS#_K4S]5C^B9TG^0[+_3'[E;K'2S]SGJIIF!"":^/*WJ'7WEWLM<
M5<YU+-*5^;AL`2.\3+@6'./:.S/0+?QB9887[W\>T&MQF)N.TXM<#R;^U2TG
M'IQ$JJ?3I!-+DLP]VMGE]HGG].T%923TX@L1@8=1^Z.^FOC)YFM.9?43W,O.
M691RS,I>SY*VFHL+S^)EMCPE!Q"1VX[<!%Y/$KT_NV/YOY__V@`,`P$``A$#
M$0``$```````*0````````!)(``````!```%0```````!`!(````!(`!`!."
M-!(!()`!F!E270)!)``(`^6N@`(!)!(!;.3!\)!!)```J$3@!`!`)(-#L6N%
MY!!)`)`Z6NY())()(!)2+7F0`````````@``````!)(```0!P```-/23(```
M`````````/_:``@!`0,!/Q#XRA5\M:O<]KR)^?DP;5"@=UT%<PM&BO!*]+6U
M0()PZJ`+(IR#=*&#.>`LR4A5WLRS:5\Y1)K5L08/C8&EB%V$*LN/_(*>0\SA
MZ<5J+B+F[/Z!>PP#3%%T/+J`!4$+J9DN<YHA$>8!87\DM"]!?62*9T2LG&M@
MYUB%*!&58W?IN8>`$.&Y.E*2>&U%&4T:(4P#K(A"0\;?@6_87(S`_P#8%JA:
MTO"\#P1]X-"P*\@,EJXFI="T-<)!3(7`07&K`PU+&B\Q_9]]\:_.&^F"(T)-
M\Q]&@;J#*<4NRR4H[5*<:1J#2(H7`>.7=9(=I,8SFU%XCIT4`5-7#Y\3A!#0
MJ47B/IZU5W2<42R<O!]Y$4-B8BG9A'B(A%:T`W`1,S(U+KDN7F5**Q0*HI03
MC`7'-=+`%EI0,A=7`NFK8"(LT96Y1'I9=*I;P6;XE*![_:XB6!8CB"<8\FBB
M`J>"-4RBWA"&A8<6V5UF/Y&U\P%G&C8&8">OZ0%;C-[S$:+(\T9T"J+,78P.
MYZN%@,2FCBY7<+JU9:CA=R@B*JO-#EW!*4UQ+/T^5,)<]R(]6/J#+N0*:521
MZ!SJV9*%)L(TDB9]9B)"VQ)0^BL:H:2096=45&A(5PF0!&SQ6R!E\K68+-MQ
M#\`I%D),D)?I75*0##G3`U*7KA9#+'!9*S+.CI&K0G6Z+5FVIVWS1V3#2T$0
MNV64R%7R4.4P,J-$&\$\JZ,RBB+*!?6"-KZ2!!U@<N;K^0A85$JG1"G<K^+C
M;=S[4*P&I1$W$Q%\@'HQOE`R78^C;TE8`A<T)\%38:6EQ4(TN39%4^M*!D.I
M1U^!T+!V+'19)%JYBCWEP`D2RM)/(5NY<9%[4;G!MT12I:S'EMJT3;"O="C0
MWZ;18!*PD&8G3N&J65-9'PH[X?8'`<#DUIE00RD#=&,MD%+=18<JC,UES6$*
M-L+;7IL)4%_)<=RU;X;;(?\`UGX!VP)(!632;S&[F'+$*59X"ZCJ!OZ>P<)5
MA6Q78'."UJJXGP0!8V!7MA556[6U^*"M*N(9(YT"G="WVHB^Q<M'Q516:H+]
M?QU1@Y6C,;7*CZUG"&1<2LSA<$WF9:'L0QF9P`_G'TE6RY-^<]3CP&)DHJ9W
MK*U:*TA<@D\$[5Q`]@"Z>"\T=QO:(>@H%R19X,(\H:S8BW<M+46/K5F&6%8:
M;KEFX[]W6ZJK+^&I=@GI"XYBUV5,K5.@5#15RS$#**$HMT"^',/BJ;59!45I
MND&;TDKEE!L;("[+\&0>UBOP?JX^S#,%NT%J-P*)I#1+0!LGV]Z'/>%)JT,X
MA6:QQ#%Q3R$S7++9D0W98D-IB7J5XMT?:=<O[`@0UI,A&JA"#DABMD+C:#33
MNY=B<(FH%D"#LCF*=B_<&TX:-4@]W92YH4*[ZB'"^\*KEA*A7PYOU+TE,M&Y
M1DS9RX*U;N'"&R9X!`<Q7FXV7EVFB_YZ`]2V4\V/OF'FG/*E*C0)]93<2#S@
MRI#];OVJ!-HG,.\4ZH.\RGI!&+U'VW%&-H".Y3R8%`'*D&$(C"M"D45#,P)3
M#=V9-L`671(VB]SDM`^IJ)!AH58AQFFK9;JUGV+VIHCU01AMPY<LEPR4Z6R=
M*$>C+/,Q6"PJB-!$/8PLP"$NC\:)*B')8&AS\=B6@BC9'D>1F[R;&+'3V"I,
ME'(6I&DZM0TL*PUC:0-*;7K9:Z3S,BKZ722M!:4;F4Z3!=W@$0`<3,6H5XD4
MAQTB+W$(].`QFH>VAET`6M%I6TIB=$/((G<\@@+$*O&5IB`N>M4]PH3A%BLZ
MW=9>JG<P45.I[[0@30C4*(]*-/:5]M72SKI:JU;_`(,TD&KX;.SJ_O`"BPN]
MO.ZO4!=PLM4,1*`"V+ZA)B6QD+8*FK@0MK*%"RS=%43%T9%)+Q`=1;HA1NU\
MOK]1+9>J;9>=%G6*N^-X;UELF4I:HMI92T8M.8$1-JA2-@9NVE<L-IOLBHL3
M93S,UY4*+5KN7?#>XB5(&A5;<KWM+N2T#:<.IC-L!=%OSEGJMGLQ"L.<)=*V
MHX1P'M!,#*O!:VO&W,`!;2P.PXR/*EHEE>%$-585+/:);&F"QIQDU1^X<H6J
MJBRM!G#?65S:MUA4P8W?)?F8$UD-%VHNQ*:S`BNV["@W3(5:$`!D%XQ3960.
M)F&\4,BKVE4W6/$^U5'!551HQ%&AY#+=(E7M,Z=0!MT[TPM(.!SQN8"U!6K-
M\TJJCIJ"D%*)FU02N]`=JB4I5`HMOW_;<`!HP'0Z>L_PE0(MNVQ`1L<8-9C`
MTH"$L66[`<U&<7'W:E#<C#D\M)M!-&2I%*$7,?,*S;R!#E)2`GJ`J<-?^2,:
MY0!R]U5?*V=@B[3WIC2S1O:ITHS[^UWT[.VOZ3H+PX.<:V;EU2\OLF7WZ!`9
M;X7I6XPT,JT;01_34R@9<7I8$QBFF%?/TTMM=N4&O@/:9^"H-9<%"UYK1*39
MW6'>OY)AJR\TVO#+5?LE_P";@.JU:5_4KO!.+R5?3A`X!=S'U'F&+0^IAD&_
M'>Q^B'R`!4U5@HC<TY-UM`6;:'<>&-*!1\$__]H`"`$"`P$_$/C8YB@TI?G^
MM7F`$*JP`'5E-#B(:=-9<?UA)=+=$1/\X#<`T"IK.2!&P\`U@T<Q.URBJ&VA
M6.<X@41&LX5-D7$!M$!G($QST@&@4Y<>/C$MJ!\/7X82+"GJ*K*(#D&"%TNC
MT[0+6;N]TH6_?<,':`MDJJ8U".TM6[=A;=.E9K,JR:[3.:M/XEZJ.^9]8,H=
MBJ8D*D-!7C%?D8=:AT^0:8@&G$;"FZ$#&5S!/BMC`%0U9PW1+7%+L=.N3+WE
M.E8#U3+9;7U1#E&NNP8*`1X=LL_9C@-BA6U0UO*0>Z/NH(E452F]?&Z*I5P`
MY;%RC>!A97*LS$>M*M\8F);';#\2Z>F/_B4\!M`>+H=6MU&"Y6S3EGAQ3>6A
M>:YV]H'EJ!$)R<-&.F-0W0(!B]=1U]5MT.K76.6"!2D39F>+UUQU^-:M!14P
M%!EPTP\N:Z&A<4(4`(UF`K;A""P+VXYVPI[=1,P^TINM\JT!&JJLO>Y5>\@"
MI;E+<MCE:JY6NIX"HL<B]1\?`BE-X@JH42\JP[EDN"=59OZ'[5+_`)6Z*C1P
M&S.L3`#(&B\[-QN707!9HN@'+C4OIU;`7WOASQ451J,`H:;7]8H5C]>L+L+&
M\Y8UN.>-#)66AU])Z7O5K[_&NE#'>.,'8N_.Y9ULJ&\5;^]XE\?EK_8($KO*
M^OO.`FQM/O\`)5/,`I"[O2OXEL0U8RPA&[;>\,T!S_$LQ8N4%'O/N;W\I1OG
MYV@ZI?0?!NR%T@=V'.8\9GL^L\CZQ*^<_]H`"`$#`P$_$/C!<'`&O']:><-J
M:*/,5HJE,F/ZQ,"&JM<>LQ&`QK#(Z[&`:B'':E;0<;XN2>-OVAM!LM#PZ?<C
M@B;,QX2[(24(7EOXQ:$;U^?>7",<H3H/('O+<;>\0MF[#5YM!"W,C3#L.=^\
M?-)TT>U@9N+`EQ;.^"SZP=:O2-X4('4VA+20M6'7,JD5;]_D$O`N!LH+BQ?/
M&(EYR(L$T-;BVYC?G>0*$E)J\18PID8"ARK%U?O#BJ&.5!15L.\5B5*%%A%J
MTO1S*O(#)1H7SGXU``I,A``<"F"=0[F;];"@YX:@MG>LQG;,V'<&#+YQO!;X
MW!+A:LUM5ULM2^LFYV%(`8&EI,8UE]YFR0@[QY0+2`V#KN%@$4(B/<[3S=-F
M^FOC.**2Q8IIX9U!6XGG'1F3TYS&]A`,E@N?8(C0ZB.+CN7STA5@Y&C1>39T
MZ28@"@:,&<AGVQ&.1A%>;1W?C@ATBH4%"8O(B/C$"RL=<758$;>&<$X<1%L1
M6/LXL&!=-:JUN5"[-]5:X8G?W$`K<E+Q`#\#*0^+#+7_`#!))1A/*/5+ZF?C
M6.SXU^)6WO*U`-,]XH[L<\0O]5E6R_0,_P"S$1CC_-?)54W824!R=T)18LWH
ME5`PJ:.T`8"\Z.<S_P",1I_R)CD\$^G5H_KJ/_&/A&AQ=2_,IW^DN%,0^<__
!V3\_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>ex99-1logo1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex99-1logo1.jpg
M_]C_X``02D9)1@`!`@``9`!D``#_[``11'5C:WD``0`$````9```_^X`)D%D
M;V)E`&3``````0,`%00#!@H-```&;0``%,H``!JH```A2__;`(0``0$!`0$!
M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0("`@("`@("
M`@("`P,#`P,#`P,#`P$!`0$!`0$"`0$"`@(!`@(#`P,#`P,#`P,#`P,#`P,#
M`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#_\(`$0@`+`$@`P$1
M``(1`0,1`?_$`0$``0`"`P`#`0$````````````'"`4&"0$#!`(*`0$!``,!
M`0$`````````````!@$$!0,"!Q```00"`0($!P`#````````!`,%!@<!`@`P
M%!$2%0@0($!08!87,2,E$0`!!`$"!`,$!@4)"0`````"`0,$!081$@`A$Q0Q
M(@=!,A4646%"4B,S$'%B0R0@,$!R1-26%S=0DE-SDS0E-@@2```$`P,'!PP#
M```````````!`@,1$@0Q81,P(5%Q(C(409'A0I(S!4!08/"AP7(C)#05-8'Q
M8A,!`0`"`0,!!P4!`0```````1$`(3%!46%Q$#!`@9&AT5#PL<'Q(.'_V@`,
M`P$``A$#$0```>_@````````````!BCFP5,.BQ=D````%,R4B>@5D)LP@FRD
MK21M:&7D`@4GH```AP_G][?&Q72Y\U\+MWFT=NR---O7XW+G[TS<+N#DP281
MB?>?`?2;H41+2D?EE_T&#CJHG)4XG7^?U^<?]>>G0]GM/"[?V$=E0RZ9]9B#
M3#WD>EWL.6E;+7\J9K\L57T-^!I:FMU4R\^[NI:N.K)VGN_S?Q]1T:B>XDXF
MT]Y7DL$0H6.LI+6]W3W_`)_0T_>THUZG+SLG58F:H/!DR(2?C/$.&8-Q(#.I
MA47#D=U^9K??XDVV4ILOAZUHB+"__P"A0WABQ,G2W1@+G2##FDE@S]``````
M`````'J.?AQ'.B9V0QC.9`>60````````````!`1PT._))X`!__:``@!`0`!
M!0+ZLTX-M%F7N>BK/GU[W"VQRCH4XPJ/=*<S-^8['8I>Z.\P^%P29WA]?Q\M
M9P89[*'AAD'S0J7N<J(^>=S5K@,<<9/(+B?WV#MK"O'_`')SUBQ";^JY0?\`
ML-:^']BK7C%8,-DIWP8\3B\CH'/9(QI1V)VI8T?3NR18IR01"UH%'I,_)RBP
M&B:.C78R-@ER-#-S3`^J[9KJ>1>!'/$D>B9%&)%&9HX9E%A3Z/6*^,\(TB5E
M+1^?V#*7.L(;*V2,02NHM8TDS&;'>V&-XGAN[;*;*ESY"&-685G:8"L_NF06
MC8#DWRFJ;#<$9]%9"0]2KW!0AVFD+@-H'-(NI4PWQLK+U-9%4JK^LHVS:GBH
M983_`#4<9TGH6\9E'_+TWT4T7K.R88^#UK+H<SUW'+NW@5LP(.`TT;7%V2<%
M^K(Q:6LM;'(SP:JK<BR+[4.7V`%5K<$WUF5?'G'LD$F#K)8M$'1EFS)6JV!_
MT>X$VH2(VA&(/":@/UY"X/;\)<(M41"36-6%T@ARJMGES<)5!7AZLYQJZP8O
M))?5TK/=(%"Y^&\OM:V[.U-=<::V#2L.L#D@HBR840)93&W<899#I(M+7)FA
M*-2P]^>W+]0=>?I[KQND%HC8Y)6;611^%QK6'Q:R8"G8C)C'ACZ???1/2Q++
MI#*!X`<QD$#]LAY:K:V-[.#]?:?8_P`ZK7^$^>)_J'I7R__:``@!`@`!!0+[
M>VAH$B=<9M.+T]!=N+B$C;8QG;.K*Y[Z^A.W"&PX33J-PPB``90A3;IH&V-9
M;2.LX=VSX,<A.Q-Z8*X6J>O8;XV1`WQL"U^7;0T?@RH*VNZ#>I@H/P5_QTVY
MR200(<041#3D2&XEWQYO4&+*[N6F<=U!SS!.(OA_FU<$=L+N"6J+4IJF1WR'
M.^1XJ*S;?A/_V@`(`0,``04"^WN!:PY/7(/#%V]:;.(DCD8SGRXV>&[3/K;9
MP=Q#*WZAZY*QI(I(IRF2G%Q'<UT@.T<\C-Q63`^F:@9OOMWVF=5#M>:&.>-L
M;AK<72.1VU5/TR*5_J\?'IG@*K*H-YBI0@:J!P[9MY>P><(M@NX8?47#%)XJ
MSA>78%;7*0*NRKGILHCV:W.S5XD0ZZ_A/__:``@!`@(&/P+S?5.NEMM-Q3GU
M^08E.VI2"'<J$M0A2#O(0*T3(:,T_P`#N5#%J&S2WIRJ_%:Q&(1*E2GDC>*Q
M;+*6GL+:A899X!FK=9)Y]XSWK"(4R:;88J4S0T:8#\?PJ>'FEFSS1LB%TQ;A
M6:CSEE)*I=0@_P#!YN83)5X@9:ND07^0,KT@R2FMG^`'AXQ,%<I/]#.NMQN4
MD[0@Y^0--Z8CZ-M_!AUDY_8(<N370UJ)Z)?.1Z2"Z+PI"B)S>4JV&@4]*B.(
MU&(I'::.)3HAG''*9<XJ:)EU8Z?>%5+49#(K;BROTSBDCY[[LETL1$_$7B.]
M!!4M>ZLX;LI9_8%+<?-C9M(HQN'[)WL=`_9.]CH"G.+4;MNY:?H3_]H`"`$#
M`@8_`O-].VWN.+@?L\@)%0LDJ,=ZD186E1"(E6Y!6HQWI##862EY5/AM*K#,
MTS*5=<*5+CIN-8FS&TK(AVE;=4TRR16<IA]51M/,*ECIT#CN(/'EFEZL+8!%
M0>\=NLLV4FIDL**'7+/SB"RH2/UN$4'0D>LAMKI#3\8V\$WCO28LI,/D-6S[
MA%!T1'K'U;C.-'JJS0$2LR::RD5)5HYC+0835^)*2:F]TDV1TA^I5"1PR@*E
MNH[MY<2!T9.HX:$(]:&@)IW(3$9V:\K\]"5>ND?)9;FOB(%0-'J4$D=$VB^8
MP2$,D_M6&=@^P;[72/L&^UTA*.&23?Q>A/\`_]H`"`$!`08_`OZ6]-L)4>%#
MC@IOR93P,,-`GB1NN*("G#L3%8;V3S!U'O"(H-,!?2+Q@4J6B+]P!%?8?"K6
M-3ZBE?W>:$VF.U/27WMUC*7OI@(GW3/]7%E%LLBBWKLZS[OI5[SS\&N/HB+P
M-O/H#CCT@_,XNT154Y:^/\WZ98W7/L-U632+!NW:<C-NNNC'Z/2Z3Q>=C3>O
MAQE&-2<4M*N!0#'*'D$K=V5PKNW5(^K(!S0MP[3/RHN[:O+]-WD%$ZTQ9PE@
M=NX^P$EL>O/C,.;F7/(6K;B\4D^2J%)FU%;+D$(H`D])ALO.J()R%%,UY<>G
M\"M>:;C9!>E!LQ<C@Z3D=#B)M;,^;)?C+S3^7DK-CBEIC0T5P=;$=L=VVV9'
M?_%,;F6?#8BKMWAH::$O\Q,R&UW.`SM8B0VU1'Y\Y[7MX;*KR%3T52+P`$5?
M9QNRS*8>-T#3F\67NZ6JKFM>34*OCB;EA8;?WCG/Z2%.7`V.'^H=)>K%<1^.
M),RZFU:-OS"0#(8=@NFB^'XB?JX&)DD6!DD/;TR[MM*ZP5OP5$EQ`[=Q=OWF
ME7Z^"8?*=BC[A*ZXW:MN2HY%]UF?$1\%3FOO""KX^*\(OS7"T7P7I3=%_4O:
M\?\`M<+_`*,W^Z\?#:.]BV$[HF_V[82`-6F]O4-.JRV*[=R?IO[Z)G-IA6)5
M=FY5T4"D%1DR#8`'.YGD#\8C78Z)+N)>9;11$3GZDXSF\H;VT]-HAV3-L"(#
MMM6+$>DL#(73\]4`?,J;OQ-"U4=5:SYWU.LZ"RMA>G4%'6B3=-%CHX8Q690M
MO`FUW9]QQ4'WMRZIQ*OW&(_SG%R(<(ZW3'M"M3T(;-6?RM4C:KM]SJI]WEP]
MZ@-^I]G<W%4RU8WE%8"KE+(8W!W<:.!/$VHLH7_#;U1/+M73C_YVR%II6!N&
M)D[HJNO1-]J*3C6OVD;<U37V\>M[]C86$^FQ2ECV<"I=E.'%C*S#%\PB,DJM
MQUD$FBJB>WB3D5_ZT7>+9&XX^[6X]45-F=+``%7M6)"Q]&7!=TY^5Q=O,E)=
M4XQEZ&TW'S7*<E+#8MH;*-QC)KIH=TPTX'20WA>`/!0%S<J)RTXL[29ZDV^4
MP7NR')*JT1>V)7)3'2D5RNOOJ'0F[>6@*H_[O&"^G.-6A4'7PZIMKFX;'66$
M9*]I!8BKJA"NC?L45523FB(O'IM%L\GFY/5/9&R=<Y8I_&0Y:/Q>[:55-TR:
M<;VJ/FTY>"<9+CD'*)V+4V)M1@3X7JC\R8^*+U'B!UDB3?N^UH@BFB:KKQG+
MMZX-M;X/8G4QYCGC/-YWMXA2MNBGTW^:K[Q!X\^?'SK_`)AV(WQP/C85`C_X
M?H*SW8PMG4Z&JL<ORMF[E^UQAU_6.V-/#MK08F:6U"P3LZKAQR-B0[#1"0F6
MY+C9*B[A]@;DUXS;*J//KCU#B5D-B6U7W[CGQ"HF(#C3<=U'=KP1YS[H:KM1
M/(NBKQCOJ%D_J/9@W.<9N1Q2O:Z=2Y7O(1L0WT;?9:$7&R1=.F>GM55X];LA
ML)TRZ>Q[+Y<&CC6,EZ0S%5^4Y$AQFT(EZ,-IUP541T\H\+DI^M]\WFVQ9J8Z
M-/8?+Z.HN]*E=`[+11\NO2Z6OU>;CTM8I37&L@]2[`:V98"V0G`%AUN-)?A(
MXBFVW+<<1P"]Y&N2+SUXQO"K/+[',J#,:^6Z!W&JRX$V*#YJ;)FZ^8CO93EN
MVD)^&J:\94]59K-P;$,<MGJ."U4-_P`?.D1U)#?D$+T<U541"74]J;D$1Y*O
M%;Z;.9O/Q.FHZ6M^8<KC1)$N[N)IP6C%`2-N>;5]LA(M#1-Y%N)=$3B-AU=F
M%EZC8S;P)3S$^U@2XUE2SHK#K^U]R2A&L1SI;57<H><53:NJ*Y\\^J&789FS
M>2;6\=>:=AXV49J:'1JQ'4(_3E"BM^9031=?/XJU\#;.5845@EJ->'YD]A([
MT>0TP/VY0`[O`?M:*B<U3BNQ!ZMPF`,,GHP6>2TYZHZ;[CBA:2A0W6G4<<V[
MB!$33GIPA`?H40KS0A?B*BI]2HNB\*!_Y%&*\E$W(A"J?0J+R5..Y:D^E=!(
M554UH<@6)'=5?OPG3?C#S^X@<-V469C%W7/J@OC%D5V153J\]&9T)Q$EQ#^A
MP$'^O[.)3D.'Z2UDB$0#(AW4-NO>47$78_'ZBJ#[!*BIJBZBOBGAPKL.9Z*Q
M'5'8KD:8RP:CX[5-HQ+;JG`_-N08:EOUG=WP>WCK$[?5.C_W#^[K::[O9P+C
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M'M9\RD0\^/4R\N>PD8_G%?&KV8S3KJR^CVZ1Y0R05D`:W!KHHD7#^,X?DF+.
MXLXZ_P!A/NJYMR[J(\DE5P`+L9&YP-VJ*A$F[FFSBLQ:9DEA)R"FD!:UN4RM
M3?:N`4BW(R))TH"[]B-BNH(B+S).<*@]1<KH_E.')CO30I&22QO$BEJV+Y=K
M'$=^G-5Y(OFVJNG%-DF&6+-'DE#%2OC=85*#+KA11"'(1`=5.F)*B:B2$*Z+
M[%2MRGU#MZ^4[1;EIJBI`AB,R"_M3Q*VWYD7G]I55$YZ)IQG&12G(A0<C=AG
M!!EQPI`(PA;^X`FA`/'EH1<>H]=D!QC@9G;.S(JPW#)YADB>-IQSJ-`(2&7"
M$D1-R:IPYB+65TBX\D9R$S8$RZEJM?L40AJJ,*;>X/(OG7:/@6G&/TV)S<:2
MUKYUD=O%LT=D5UC!F..N,L-.K&1T'&R/G[G&=S\[6G[O/885TRIQMI8U9`A@
M)?B,Z@"=XKJH:*B+H2:ZJJKQ4TC&5T5O@$"9HK4R*8W05.IKVK*]L?3,%5-$
MZJBGLT3EQZHTF4N1':_.\@F6,1:]YPWXT9YQUV.Z?58;1N7'=431$W#JG#6)
M0\LQ5K'(^V/'R#X6'S$S7"6H,CK#4^N`<D_$^KJ:<>D[D"R&:Q@EJ,NUF7,E
MTK&>T/9:N@K;)@Y(<6.2Z+L%.2)RXP',8CL$:O&(]BU8-O.NC,,I0/"WVS8L
MFV:)U.>I#Q=WOI1DM370<DD+-M*&]CD[%:G$I&;T7;'DCM(R54]PA0MNI)IQ
M2YYC%M4P<\CTT2MR!F?&21179!'`'R0#8>Z6CFJ#J',$'W5'7B3DN<9+#.0<
M0HD'',<9&)1Q]_\`:9:"PQW+P?930N:ZJ2Z)I7TN:3<)6FAV;$QW(:Z(XE^[
M&C.$J,,?P[2-$ZV6B^X.OCKP()X"*"FO-=$33FOMX<F2&"I[TAY7=8(`\Z7L
M[^,OX$\4_:T<^@DX67506,IKF2ZB.5C:25,$YZ3*21^.7+Q1OJI]?'99%Z28
MVY/9\KQ"MK4OZIXJ[`?-W8?ZE%/JX[6K],,,[I?=C3LC*L=<7Z&OB#L<'E_J
MJJ\-ED/I!B<)V6*]K$3(NYE2!5/?[:*^ZZD;]M40.)F10\'8RFE823#6),EC
M7U_=OD+@BP\XZV;RP@33RZZ:IKSX_P!!<=_Q$/\`>>/]!<=_Q$']ZX@P6_3"
MNAP&>WBB#60Q!"-$#:VB`FI:"TTG+E[/T7-"4A8HW%;,KEDBVCI,)+9-GJHV
MI`AJ&[735->*7&0EE/"GB=HDPVD8)_\`$<<WJR)N('O_`$KQ#IG;-RJ&'<PK
M=)#<8)2FL,7Q1CIFZRB(YUO'7EIPB?0FG]()QPQ;;;$C-PR00`!34B(BT01%
M$YKP[#R+X5F$D$44AUL)NUD"2)X!9!L8BK]:/BJ<%'].L.N(T=SD%4,MZ\>1
M=WYQN]$1A-?41D@_?X8M/46<K+0H"I0P9*ORW`#W&9]DA$##*)^[9W+I]L>(
MU95PX\"!#;1F-$BMBTRRV/L$1^GVKXJO-?\`8&8_$N^['X%-[CX;IWNW9Y>C
MN\GOZ;MWEV:Z\N&?G;YB[W<FGQ'3Y>^K=\&_BM/^9Y>&_DOX%\)\NWX#V?;:
MZ<NIVG[W3QW^;^5__]H`"`$!`P$_(?BPBX6]OJ6#B"Q,R='2#F).%#)#Q`>9
M[!QAMENB:+=9('D7NM7D\.T>NP\\VGO@2.6L\?P]HWMFEK98L7AWFV'I`*9>
M`T&L-MQ;Y":G5_I[*?\`.^!R83I0"CW%6?\`=NH*EC8LL-CW1HUEZ<[$+T4[
M@83X.PB/"^"K@"JK=)O]M*]UQVMA!?"I8M%51P8*[S<NX0GL%.H0W%B&+L#=
M^VVA/!;`KWJ87`R5H*EA8-D48#C70VGRB6K1;`H&H[5*5;'>\O.YEI*\:OD1
MRY,0@3L@VP8;T"YYF09*3Y)$<=!.1STN00)$$,O@S7(:4[5R482FX%MGU[;T
MQ40Y0()RVD<V'-IG$"?<S4HIM-Y4@HUY[1C%#!34Z1)/$)TX!<PE0U@*68OT
ML;+C6GVGWJ"*"-3=F5JT%7`*6D&63<57/2>4,*SC)M$,/HH<6!&8\>.BM\84
MJLWB+E.)Y,+]WB&0.:Z^YV@)>Z!I:LCW`&P=;!TW'S'ZWH"<!(<;V_/M%G:!
MP:T@,F$@7E@`IP"MA-\%JZT7&@W*:-A<CD9@<7`*N*'<*H)A"EJR6E-0=\?4
MB8)51N.""_J=H)/E$P9"&-@J8+&852W+2MJ)C(&+-9M=(76(H'H';.N#HE8D
M;U&B,3#7M\'G1`"Q!<FF#F3"^B$-`])$YDE9(AUS2]XUL`198NRNB5*@A`8V
M<E'L$!AWH(QA'&EBKUQGE@^-32BRX=8L51$CKNJJ$TP=)Z*\I!5%]M&(Z4;P
M/^7%"].B<;EW]`:\9`F`CBG;,25F(%?(L2>B`P,1PEX"P_ON_C2K,)5&&HL%
M%A51`&$SI[?@8"^92IK!!FXM:4Y`5N*`[M$A*0B$?>(%7&V0%XMT+5,")PG%
M<6W):&$DSWSKUMC4Z#5"#!A9T@X;$E"POS4U<>08OS[>7I0-)1$RG;3BB*63
ME`I`X*/.L8UA0`\L"-B=J&"%-J'..,6`)'&G=!#0L7Y6IIH"Q^4,]9Q5VA-H
M\^(&$Z4"W/*IT\9@3:%7#KG<N.!76;(A;`I]Z(S/3V5W"FI(=-N9:HKV%59>
M%IXLD4<X&>8GRQ#XPXL;8#-^')-L]!SK!"N\)\0ZZ)6I^52B`&:UPT6#?YK"
M.TA!CR9M^?S#D4M4.!*%>$)G$J;20<%6TJE%5_0/Z3#'@_[H6?QKB^[9?G:S
MPM_;%7W/_7__V@`(`0(#`3\A_3W4(9(CU)UX^`1+:4T7UP_Q_P`YZF,`^O&:
MS5W@?T86;^HH^SG[(_.;N]*DKQU][V+$U:;^K[8/!KEU*>$W]LZ\#P#Z$ZI]
M_3!I^6D**[G!WQW0/+_U?Y\8;VJ/H/J1W[Q4$.N9]1'SUPTO]1(X]+^H?=Q)
M,N%L/E<"'1#!.Z6>6!Q`-F#T1-?+/0TH/HN*MLN<KKPX[8BJT/=I$?=,_>-=
MS.;C_J[!^^7O@K$=O&YQB2P5="ZIZ)3(5J+3S^6_JP5!%ZM!_7O'9,XMWH.O
MHTS1F[RA]3>&6+I1]AQ;KVG,Z-B/5SS9%B7HB3\9_@,?XC!C/79?L?C]9OO^
MD__:``@!`P,!/R']/;4Y:''9VY^`-B5G+/3.G]I_&>B8D_C#16';\9,@.B#_
M`!G^"_C--HLWP?+WOD_@/#Z/OC5.>Z6'S,\D!BG?Y_;-^M#N+*^?/C#TYT<'
M\'B=,!&%!Y*^Y[RYXVX">AIF@IZ*#]\+^8@OX,%/8)#]9D_0.*;V'E\8Q2]T
M!/B/+YYY1L$_@S2YAP>#EY[X`&Q>[-V*5+_J/K@+4[)AWQ2-Z[]L$L*H<AN?
M,8YTAPE\'AVQL5XAM/\`?O8]\[F_HCGT^YGV<4`SJL_DPP51Z;R1M,T>!PB#
MFT;^<_V^._/UXC)T-<3_`,/C_/7/'3])_]H`#`,!``(1`Q$``!``````````
M````1"```````#;:`````".)L4"0"20#YZX02021)1*JT22`"0X6@2@200,8
M/"\00````````````2U_D``````````````0``#_V@`(`0$#`3\0]W3O\`T,
M6V`'T&D:Z*LQ0=JDTKENFHP1SM'!JHM@4O\`2,B1VA/)N>Z6'W,O7I[`9:-M
M2MN8C9>,,+&0)0`;B51J>PZ*S,X$AT[@;#.I!@\&T=G0-&-LTQNT.50=.S+]
MM?OUSR&N=\>O;*2TG?IE/;.?#@]B05</P^X#V/#G``^M#0P09.B[5]8*<`W/
M;[[MK\M"1-@P1C(Q#,=.UOD&B6,,J$GY+\=#W[R-0/.%S]H_MK`3Q*1U7&))
M4E3V)P9=]BQXDHF948![:F4L)9$R3L5)A@KI<TZE94Q4`D$#3BC%7EEYJ)-&
MY>>2891-Y#&PGDLR*/$7`SY]VP8X`F-LX6J9C"<5M&7ZLBN+.3G/]O;`73EY
M1@6.1Y!X[*"SOCZT*L)(#%<6#1?5R%I\?TG`;?6W-8Q5O(:M83?U0'FRBJ`D
M'"%M?M`Q$J`$F0WW3\E_;U@L8.A0V,M+EJ.<GX`%N$J_Q#,@*H4"!^!&5IV8
M>%"!\>,UH$9+2>?U2&^6'%M;.+WBAR;TPH4=IA7_`/Y(@EJ%T(3_`&8&WY`O
M=DK0VO-N"(L62VK1K0'0FPLPO*'9&\6\8OY&86=Q5L2B*)ADWL\JMB1`B9MR
M'Y."@6LZ<9>SO,@%&J;NTW%2WW%[;T#DS*EP#/Z$H,2&4,9<^9DWLIH7.ZX,
M$*+,1J7RA%'$9<U36`=H0>9XD-,)5K:DD/!>S42N%O<,9#8]?M"+G#Y)R7!3
M/8EO9$D1P0[*BZ-U"(RU4.>I^-5@@:NP:Y6(S`.@"Q$G!7>UZ37$%).\!IE.
M7H=H@K8LI@6'[THQ*%F$`=%>X?:YL%8,.)=Y:Y'0/68>MZ;Z"32*@H;M6#K*
MNR`Q0FRML512N0G/F_\`^U@0BTC<?@3CYK7K!-@LER=^+3GKE02HO)H\%$@"
M$>"003$9"DQJ2ML`PNV5.K4E6\#!ZIK=$_;L)%@"9+^8V6T#=')/`3^(72PG
M'/=,T0')N3.JLAX=Q&YN%-"D*MKO!#D)(!DJDWTDS=`R.&US)13L.$#L.3(%
MQ4(]!C^TW`,"LI;.`-0C@POS3I8+AY*F;7=4&G$A[-:!+CI-"/1['!D'QDCF
MYS2"+[*//T92WR00BW*:@UUC?NNI5W@^<A'MIS1@`LS9_*A-*IN6?$)X(PU6
M6B3%0,-Q<N@6N:HW0H&.DD731'<KR^ACHK6'@XH6]<D-,]BTNA&^H$3R_?\`
M.3R_?\Y'O]?CI]\*G?\`9S$_AX;E_6>"[/ZYO._]?__:``@!`@,!/Q#XR/LH
M\?`4XQZW`#&P('2B.#=^<I+TRSWM'Z.X702#.LXXRG>KN[_/^^,"E38)VBCL
MC'!3>4J[*_R9QIA</14<L#K>,]54\0I#%%C.\R^\-,<M42G.AP.E(*F$)W":
MH@M4%]5P3&[7Q(,>X!N.RKH8O<1FLBX:Z>`XZ9C!7WM0]WU\V:1F'ALE:S`S
M4`+JB^[>'OEE5)4'D7&=M)V#@+:(W@Y$0_7+^5U/TU_C!I)K_4D4?7*X2O<<
MA7<5>]REN-T=T5]%HX7('JM-"QI+V>ES>"BZ)U!">YKNXQ%1$2(G(CP^/=E"
MRR1P&Z\#L0$Y14`P`#-":"]7@A6@QZ:&[J76\;T8')!$"$$53(Z8ZWFOZ!FO
M2?(C+-#!K4``%70NJIOWE=AE+J+5\N]\@.3^\H#NA@\".=.ME?.!^^+%9%J"
M$(6G0'APNN,!A&G"=JQ$3V!)\`Y`CK:A=[?+G8_'Q&]IQV^TQ==E+%Y#H7QY
MR1\?OZY<N,>?T7__V@`(`0,#`3\0_3P<6W"E@2*M]F>,ZSKAOCWNV)!O8*!0
M>_7."#TU_7!9L!WG?>J/<FL(-;(%4\#;Z8CYK"'J)<^38]V9Q`Z*['%/>GX1
M/LT@7GDG**@.6<8`:@SNB".N'!P`4DVC70#\D"JXVYQHCC<=$*ZX#SZ@V4==
M;U[CT;P4;8.!$>PHAT&>UU[D!)[;Z@#0:!->F%NLR.:-(":G3/*P&?6N"$G/
MJ3_+-[03L31!IZ$+U,+#:&!S2`(<"$WG2XM='G8O'3-%W=NSG!T]';&X`41H
MCU$TGGW:TTFH*PZ<CA$0FA-3$&1'*H%]*J%@3$-3I*B[$.K6VXK[8=2I(@"`
M-C(Y:350:>643F+#AF+0M6E!.T*S;7M=ON3FX8N,&)^9#Q9G(N^H?`NCZDSK
ME#GZU/MA,:Q:(BA=*@;7+E5-3)OR'0&HK[#&_P"B6\8X<5PFLUSZB?'K70[N
49],&'<;'9?'7(!#-YO-_HO\`_]D_
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
